Over a week ago
On The Fly
Show Hide Related Items >> <<
03/29/21 Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials 03/29/21 Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials 03/04/21 Wave Life Sciences cash runway expected into 2Q23 01/11/21 Wave Life Sciences announces 2021 key upcoming milestones 03/29/21 Visa to settle transactions in USD Coin 03/22/21 Kaleyra announces agreement with Visa in Latin America, Caribbean 03/19/21 Visa drops 2% after WSJ says debit card practices under investigation 03/16/21 Visa appoints Michelle Gethers-Clark as Chief Diversity Officer 03/30/21 Spotify acquires Locker Room creator Betty Labs; financial terms not disclosed 03/11/21 Polestar now features Spotify Group Sessions Beta 02/22/21 Spotify announces new partnership with 'Avengers: Endgame' directors 02/22/21 Spotify announces new podcast with former President Obama, Bruce Springsteen 03/30/21 PayPal launches Checkout With Crypto 03/16/21 Flutterwave, PayPal partner to help African merchants accept, make payments 03/09/21 Chase Pay to be removed from all merchant apps, websites by March 31 03/08/21 PayPal to acquire Curv, terms not disclosed 03/30/21 BioNTech says evaluation of safety of third BNT162b2 dose initiated 03/30/21 BioNTech: Signed orders for 1.4B doses of BNT162b2 to date for delivery in 2021 03/30/21 BioNTech, Pfizer to increase BNT162b2 manufacturing capacity to 2.5B doses 03/29/21 CDC estimates real-world mRNA vaccine effectiveness of 90% at full immunization 03/30/21 Illumina to oppose FTC's challenge of Grail acquisition 03/30/21 Illumina down 5% after FTC challenges proposed acquisition of Grail 03/30/21 FTC challenges Illumina's proposed acquisition of cancer detection test maker 03/30/21 FTC challenges Illumina's proposed acquisition of Grail 03/29/21 Canoo sees Q1 operating expenses $45M-$50M 03/29/21 Canoo names Renato Giger as interim CFO 03/11/21 Canoo say production version of EV pickup truck opens for preorders in Q2 03/09/21 Telus International names Maria Pardee as chief commercial officer 02/17/21 DXC Technology signs strategic agreement with Temenos 02/02/21 DXC determined Atos proposal to be 'inadequate and lacking certainty' 02/01/21 Atos board decides not to pursue transaction with DXC Technology 03/30/21 DraftKings acquires Vegas Sports Information Network, terms not disclosed 03/29/21 DraftKings rises 0.8% afterhours following disclosed purchased by Cathy Woods 03/29/21 DraftKings to become official gaming partner of WWE 03/25/21 Nevada reports statewide February gaming win down 26% to $772.41M 03/25/21 Citron's Left says 'still involved' with RH 03/24/21 Tesla now accepting bitcoin as form of payment for cars 02/12/21 Twitter CEO, Jay-Z partner to establish bitcoin development fund 02/11/21 BNY Mellon announces formation of new digital assets unit 03/30/21 BioNTech accelerating development of broad oncology pipeline 03/29/21 American Airlines now sees Q1 system capacity down 40%-45%, up from prior view 03/08/21 American Airlines announces proposed offering of senior secured notes 02/22/21 American Airlines appoints Adriane Brown to board of directors 02/18/21 JetBlue launches first phase of codeshare with American Airlines 03/31/21 Canaccord Canaccord upgrades Illumina, says worth owning with or without Grail 03/31/21 Canaccord Illumina upgraded to Buy from Hold at Canaccord 03/31/21 Atlantic Equities Illumina downgraded to Neutral from Overweight at Atlantic Equities 03/31/21 Piper Sandler Illumina should be bought on weakness from FTC challenge, says Piper Sandler 03/17/21 Mizuho AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho 02/23/21 B. Riley B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/10/21 KeyBanc Maravai Lifesciences price target raised to $39 from $33 at KeyBanc 02/04/21 DZ Bank Pfizer upgraded to Buy from Hold at DZ Bank 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 01/29/21 Piper Sandler Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 03/19/21 Susquehanna PayPal chances of crypto success likely, says Susquehanna 03/12/21 Fly Intel: Top five analyst initiations 03/12/21 Redburn PayPal initiated with a Buy at Redburn 03/12/21 Redburn PayPal initiated with a Buy at Redburn 03/19/21 JPMorgan Visa has 'navigated heavy regulatory oversight' before, says JPMorgan 03/19/21 Wells Fargo Visa selloff on WSJ story likely a buying opportunity, says Wells Fargo 03/19/21 Barclays Visa, MasterCard facing new DOJ scrutiny on debt practices, says Barclays 03/16/21 Morgan Stanley Visa price target raised to $253 from $233 at Morgan Stanley 01/13/21 Standpoint Research Bitcoin could hit $112,000 this year, says Standpoint Research 03/23/21 China Renaissance China Renaissance downgrades Tencent Music to Hold after Q4 earnings 02/23/21 Fly Intel: Top five analyst downgrades 02/23/21 JPMorgan Spotify price target raised to $385 from $350 at JPMorgan 02/23/21 Atlantic Equities Spotify downgraded to Neutral from Overweight at Atlantic Equities 03/30/21 Loop Capital Loop Capital recommends buying DraftKings going into NY budget deadline 03/23/21 Goldman Sachs DraftKings price target raised to $87 from $79 at Goldman Sachs 03/18/21 JPMorgan Micro-betting market in U.S. 'could be substantial,' says JPMorgan 03/14/21 Jefferies FanDuel IPO in U.S. would be 'major catalyst' for Flutter stock, says Jefferies 03/30/21 Deutsche Bank Deutsche upgrades 'cleaned up' DXC to Buy with $44 price target 03/29/21 Deutsche Bank DXC Technology upgraded to Buy from Hold at Deutsche Bank 02/19/21 BofA BofA upgrades DXC Technology to Neutral, says 'worst is likely over' 02/19/21 BofA DXC Technology upgraded to Neutral from Underperform at BofA 03/30/21 Fly Intel: Top five analyst upgrades 03/30/21 Jefferies Jefferies upgrades American Airlines to Hold on outperformance potential 03/30/21 Citi Citi takes 'cautious view' on American Airlines capacity additions 03/30/21 Jefferies American Airlines upgraded to Hold from Underperform at Jefferies 03/30/21 Truist Wave Life Sciences price target lowered to $17 from $27 at Truist 03/30/21 Mizuho Wave Life Sciences price target lowered to $7 from $21 at Mizuho 03/30/21 RBC Capital Wave Life Sciences price target lowered to $8 from $13 at RBC Capital 03/23/21 Truist Truist sees mixed readthroughs to Wave's toplines from competitor HD setback 03/30/21 Roth Capital Canoo downgraded to Neutral at Roth Capital on 'complete change in direction' 03/30/21 Roth Capital Canoo downgraded to Neutral from Buy at Roth Capital 03/11/21 R.F. Lafferty Canoo initiated with a Buy at R.F. Lafferty 03/04/21 Wave Life Sciences reports Q4 EPS (59c), consensus (61c) 11/09/20 Wave Life Sciences reports Q3 EPS (86c), consensus (69c) 01/28/21 Visa reports Q1 EPS $1.42, consensus $1.28 01/28/21 Notable companies reporting after market close 01/25/21 Fly Intel: What to watch in credit card space earnings reports 11/02/20 Fly Intel: What to watch in PayPal earnings report 02/03/21 Spotify sees Q1 revenue EUR 1.99B-EUR 2.19B 02/03/21 Spotify sees FY21 revenue EUR 9.01B-EUR 9.41B 02/03/21 Spotify reports Q4 EPS (EUR 0.66) vs. (EUR 1.14) last year 02/02/21 Notable companies reporting before tomorrow's open 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/03/21 PayPal sees Q1 adjusted EPS growth of about 50%, consensus 99c 02/03/21 PayPal sees FY21 adjusted EPS up about 17%, consensus $4.54 02/03/21 PayPal reports Q4 adjusted EPS $1.08, consensus $1.00 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open 02/11/21 Illumina sees FY21 adjusted EPS $5.10-$5.35, consensus $6.11 02/11/21 Illumina reports Q4 adjusted EPS $1.22, consensus $1.11 02/11/21 Notable companies reporting after market close 01/11/21 Illumina sees FY21 adjusted EPS $5.10-$5.35, consensus $6.61 03/29/21 Canoo reports Q4 EPS (8c), one estimate (14c) 02/04/21 DXC Technology sees Q4 EPS 65c-70c, consensus 69c 02/04/21 DXC Technology reports Q3 EPS 84c, consensus 54c 02/04/21 Notable companies reporting after market close 02/02/21 DXC Technology says guidance exceeded for Q3 02/26/21 DraftKings raises 2021 revenue view to $900M-$1B from $750M-$850M 02/26/21 DraftKings reports Q4 revenue $322M, consensus $232.6M 02/25/21 Notable companies reporting before tomorrow's open 01/28/21 American Airlines reports Q4 adjusted EPS ($3.86), consensus ($4.11) 01/27/21 Notable companies reporting before tomorrow's open 10/22/20 American Airlines reports Q3 EPS ex-items ($5.54), consensus ($5.88)
On The Fly
Show Hide Related Items >> <<
03/29/21 Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials 03/29/21 Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials 03/04/21 Wave Life Sciences cash runway expected into 2Q23 01/11/21 Wave Life Sciences announces 2021 key upcoming milestones 03/29/21 Visa to settle transactions in USD Coin 03/22/21 Kaleyra announces agreement with Visa in Latin America, Caribbean 03/19/21 Visa drops 2% after WSJ says debit card practices under investigation 03/16/21 Visa appoints Michelle Gethers-Clark as Chief Diversity Officer 03/30/21 PayPal launches Checkout With Crypto 03/16/21 Flutterwave, PayPal partner to help African merchants accept, make payments 03/09/21 Chase Pay to be removed from all merchant apps, websites by March 31 03/08/21 PayPal to acquire Curv, terms not disclosed 03/30/21 BioNTech says evaluation of safety of third BNT162b2 dose initiated 03/30/21 BioNTech: Signed orders for 1.4B doses of BNT162b2 to date for delivery in 2021 03/30/21 BioNTech, Pfizer to increase BNT162b2 manufacturing capacity to 2.5B doses 03/29/21 CDC estimates real-world mRNA vaccine effectiveness of 90% at full immunization 03/30/21 McCormick reports Q1 adjusted EPS 72c, consensus 58c 12/30/20 McCormick acquires FONA International for $710M in cash 11/30/20 L Catterton completes sale of Cholula to McCormick for $800M 11/25/20 McCormick recommends stockholder reject mini-tender offer by TRC Capital 03/29/21 Canoo sees Q1 operating expenses $45M-$50M 03/29/21 Canoo names Renato Giger as interim CFO 03/11/21 Canoo say production version of EV pickup truck opens for preorders in Q2 03/25/21 Citron's Left says 'still involved' with RH 03/24/21 Tesla now accepting bitcoin as form of payment for cars 02/12/21 Twitter CEO, Jay-Z partner to establish bitcoin development fund 02/11/21 BNY Mellon announces formation of new digital assets unit 03/30/21 BioNTech accelerating development of broad oncology pipeline 03/10/21 AbCellera notes 'second positive Phase 3 trial readout' for bamlanivimab combo 02/11/21 AbCellera names Ester Falconer CTO 02/09/21 AbCellera's Bamlanivimab gets FDA EUA for COVID-19 treatment 01/27/21 AbCellera-found antibody, bamlanivimab, to be developed with VIR-7831 for Covid 03/17/21 Mizuho AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho 02/23/21 B. Riley B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/10/21 KeyBanc Maravai Lifesciences price target raised to $39 from $33 at KeyBanc 02/04/21 DZ Bank Pfizer upgraded to Buy from Hold at DZ Bank 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 01/29/21 Piper Sandler Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 03/19/21 Susquehanna PayPal chances of crypto success likely, says Susquehanna 03/12/21 Fly Intel: Top five analyst initiations 03/12/21 Redburn PayPal initiated with a Buy at Redburn 03/12/21 Redburn PayPal initiated with a Buy at Redburn 03/19/21 JPMorgan Visa has 'navigated heavy regulatory oversight' before, says JPMorgan 03/19/21 Wells Fargo Visa selloff on WSJ story likely a buying opportunity, says Wells Fargo 03/19/21 Barclays Visa, MasterCard facing new DOJ scrutiny on debt practices, says Barclays 03/16/21 Morgan Stanley Visa price target raised to $253 from $233 at Morgan Stanley 01/13/21 Standpoint Research Bitcoin could hit $112,000 this year, says Standpoint Research 03/17/21 Fly Intel: Top five analyst downgrades 03/17/21 Argus McCormick downgraded to Hold at Argus on weaker outlook post-pandemic 03/17/21 Argus McCormick downgraded to Hold from Buy at Argus 11/24/20 Stifel Stifel sees McCormick's acquisition of Cholula brand as 'strategic' 03/30/21 SVB Leerink AbCellera price target lowered to $45 from $52 at SVB Leerink 03/24/21 BMO Capital AbCellera price target lowered to $59 from $61 at BMO Capital 02/08/21 SVB Leerink AbCellera price target raised to $52 from $45 at SVB Leerink 01/26/21 Berenberg Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg 03/30/21 Truist Wave Life Sciences price target lowered to $17 from $27 at Truist 03/30/21 Mizuho Wave Life Sciences price target lowered to $7 from $21 at Mizuho 03/30/21 RBC Capital Wave Life Sciences price target lowered to $8 from $13 at RBC Capital 03/23/21 Truist Truist sees mixed readthroughs to Wave's toplines from competitor HD setback 03/30/21 Roth Capital Canoo downgraded to Neutral at Roth Capital on 'complete change in direction' 03/30/21 Roth Capital Canoo downgraded to Neutral from Buy at Roth Capital 03/11/21 R.F. Lafferty Canoo initiated with a Buy at R.F. Lafferty 03/04/21 Wave Life Sciences reports Q4 EPS (59c), consensus (61c) 11/09/20 Wave Life Sciences reports Q3 EPS (86c), consensus (69c) 01/28/21 Visa reports Q1 EPS $1.42, consensus $1.28 01/28/21 Notable companies reporting after market close 01/25/21 Fly Intel: What to watch in credit card space earnings reports 11/02/20 Fly Intel: What to watch in PayPal earnings report 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/03/21 PayPal sees Q1 adjusted EPS growth of about 50%, consensus 99c 02/03/21 PayPal sees FY21 adjusted EPS up about 17%, consensus $4.54 02/03/21 PayPal reports Q4 adjusted EPS $1.08, consensus $1.00 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open 03/30/21 McCormick raises FY21 adjusted EPS view to $2.97-$3.02 from $2.91-$2.96 03/29/21 Notable companies reporting before tomorrow's open 01/28/21 McCormick sees FY21 adjusted EPS $2.91-$2.96, consensus $2.96 03/29/21 Canoo reports Q4 EPS (8c), one estimate (14c) 03/29/21 AbCellera reports FY20 EPS 45c, consensus 60c
On The Fly
Check out this morning's…
Show Hide Related Items >> <<
03/29/21 Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials 03/29/21 Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials 03/04/21 Wave Life Sciences cash runway expected into 2Q23 01/11/21 Wave Life Sciences announces 2021 key upcoming milestones 03/30/21 Vipshop announces $500M share repurchase program 03/26/21 Discovery, Farfetch weakness attributed to block trade offerings 11/12/20 Vipshop rises 6.6% 11/02/20 Vipshop appoints Pengjun Lu as co-CTO $2.08 / +1.055 (+102.93%)
03/29/21 SeaChange secures multi-million-dollar contract with broadband service in U.S. 02/11/21 SeaChange appoints Matthew Stecker to board of directors 01/13/21 SeaChange appoint Robert Pons as executive chairman, initiates CEO search 03/30/21 Qiwi sees FY21 net revenue down 15%-25% over 2020 03/30/21 Qiwi CEO Boris Kim to resign, Andrey Protopopov recommended to succeed 03/03/21 Qiwi CFO Pavel Korzh resigns 12/10/20 Qiwi sinks after Central Bank of Russia puts restrictions on Qiwi Bank 03/30/21 BioNTech says evaluation of safety of third BNT162b2 dose initiated 03/30/21 BioNTech: Signed orders for 1.4B doses of BNT162b2 to date for delivery in 2021 03/30/21 BioNTech, Pfizer to increase BNT162b2 manufacturing capacity to 2.5B doses 03/29/21 CDC estimates real-world mRNA vaccine effectiveness of 90% at full immunization 01/06/21 Vaxcyte announces publication of preclinical PoC data of VAX-A1 12/22/20 Vaxcyte appoints Andrew Guggenhime as president 03/26/21 Republic Services appoints Brian Tyler to Board of Directors 03/01/21 FedEx begins shipping newly approved Covid vaccine on behalf of McKesson 12/20/20 Fly Intel: Top five weekend stock stories 12/20/20 FedEx to ship first wave of Moderna COVID-19 vaccines across the U.S. 03/29/21 Danimer Scientific to invest $700M to expand Bainbridge operations 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel 01/29/21 Danimer Scientific falls -12.2% 01/21/21 Greenlight discloses new positions in Resideo and NCR, discusses FuboTV stake 03/30/21 BioNTech accelerating development of broad oncology pipeline 02/01/21 AngioDynamics appoints Richard Rosenzweig SVP General Counsel 02/01/21 AngioDynamics appoints Richard Rosenzweig SVP General Counsel 11/12/20 AngioDynamics presents safety, efficacy results from RAPID outcomes data 03/10/21 AbCellera notes 'second positive Phase 3 trial readout' for bamlanivimab combo 02/11/21 AbCellera names Ester Falconer CTO 02/09/21 AbCellera's Bamlanivimab gets FDA EUA for COVID-19 treatment 01/27/21 AbCellera-found antibody, bamlanivimab, to be developed with VIR-7831 for Covid 03/17/21 Mizuho AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho 02/23/21 B. Riley B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/10/21 KeyBanc Maravai Lifesciences price target raised to $39 from $33 at KeyBanc 02/04/21 DZ Bank Pfizer upgraded to Buy from Hold at DZ Bank 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 01/29/21 Piper Sandler Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 12/11/20 Goldman Sachs Qiwi downgraded to Neutral from Buy at Goldman Sachs 12/10/20 William Blair Qiwi government audit to bring business changes, says William Blair 12/09/20 JPMorgan Qiwi downgraded to Underweight from Neutral at JPMorgan 11/23/20 Qiwi downgraded to Sell from Buy at Sberbank CIB 02/26/21 Macquarie Vipshop price target raised to $52 from $33 at Macquarie 02/01/21 Morgan Stanley Vipshop user engagement to underpin 'solid' user growth, says Morgan Stanley 02/01/21 Morgan Stanley Vipshop upgraded to Overweight from Underweight at Morgan Stanley 01/26/21 KeyBanc Vipshop downgraded to Sector Weight at KeyBanc on lack of drivers 01/08/21 Canaccord AngioDynamics price target raised to $18 from $14 at Canaccord 11/25/20 Fly Intel: Top five analyst upgrades 11/25/20 Raymond James Raymond James upgrades AngioDynamics to Strong Buy on 'compelling' risk/reward 11/25/20 Raymond James AngioDynamics upgraded to Strong Buy from Market Perform at Raymond James 03/30/21 Argus McKesson upgraded to Buy from Hold at Argus 03/02/21 Cowen McKesson price target raised to $224 from $210 at Cowen 02/03/21 Credit Suisse McKesson price target raised to $192 from $178 at Credit Suisse 02/03/21 Deutsche Bank McKesson price target raised to $231 from $222 at Deutsche Bank 07/16/20 Wells Fargo Sutro Biopharma initiated with an Overweight at Wells Fargo 07/07/20 Fly Intel: Top five analyst initiations 07/07/20 BofA Vaxcyte initiated with a Buy at BofA 07/07/20 Jefferies Vaxcyte initiated with a Buy at Jefferies 02/09/21 Jefferies Danimer Scientific price target raised to $66 from $49 at Jefferies 01/06/21 Jefferies Danimer Scientific initiated with a Buy at Jefferies $2.08 / +1.055 (+102.93%)
09/09/20 Lake Street SeaChange price target lowered to $2 from $4 at Lake Street 04/08/20 SeaChange participates in a conference call hosted by Lake Street 03/30/21 Truist Wave Life Sciences price target lowered to $17 from $27 at Truist 03/30/21 Mizuho Wave Life Sciences price target lowered to $7 from $21 at Mizuho 03/30/21 RBC Capital Wave Life Sciences price target lowered to $8 from $13 at RBC Capital 03/23/21 Truist Truist sees mixed readthroughs to Wave's toplines from competitor HD setback 03/30/21 SVB Leerink AbCellera price target lowered to $45 from $52 at SVB Leerink 03/24/21 BMO Capital AbCellera price target lowered to $59 from $61 at BMO Capital 02/08/21 SVB Leerink AbCellera price target raised to $52 from $45 at SVB Leerink 01/26/21 Berenberg Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg 03/04/21 Wave Life Sciences reports Q4 EPS (59c), consensus (61c) 11/09/20 Wave Life Sciences reports Q3 EPS (86c), consensus (69c) 02/25/21 Vipshop reports Q4 EPS 54c, consensus 49c 11/13/20 Vipshop reports Q3 EPS 27c, consensus 26c 03/30/21 Qiwi reports Q4 revenue $84.5M, one estimate $87.62M 11/19/20 Qiwi reports Q3 EPS 61c, consensus 60c 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open 03/29/21 Vaxcyte reports Q4 EPS (41c), consensus (54c) 02/02/21 McKesson raises FY21 adjusted EPS view to $16.95-$17.25 from $16.00-$16.50 02/02/21 McKesson reports Q3 adjusted EPS $4.60, consensus $4.13 03/29/21 Danimer Scientific reports Q4 EPS (26c) vs. (15c) last year 03/30/21 AngioDynamics raises FY21 adjusted EPS view to 4c-6c from 0c-5c 03/30/21 AngioDynamics reports Q3 adjusted EPS 2c, consensus (2c) 01/07/21 AngioDynamics sees FY21 EPS 0c-5c, consensus 2c 01/07/21 AngioDynamics reports Q2 EPS 1c, consensus (2) 03/29/21 AbCellera reports FY20 EPS 45c, consensus 60c
Recommendations
Truist analyst Joon Lee…
Truist analyst Joon Lee lowered the firm's price target on Wave Life Sciences to $17 from $27 but keeps a Buy rating on the shares. The company's failed Huntington's disease trial data were disappointing, with SNPs 1 and 2 results leading to the programs beeing terminated, however its HD-SNP3 program - supported by in vivo knockdown data - will still advance to the clinic in 2021, the analyst tells investors in a research note. Lee adds that he remains positive on Wave Life's clean break from the older oligo platform, with focus on 5 major programs.
Show Hide Related Items >> <<
03/29/21 Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials 03/29/21 Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials 03/04/21 Wave Life Sciences cash runway expected into 2Q23 01/11/21 Wave Life Sciences announces 2021 key upcoming milestones 03/30/21 Mizuho Wave Life Sciences price target lowered to $7 from $21 at Mizuho 03/30/21 RBC Capital Wave Life Sciences price target lowered to $8 from $13 at RBC Capital 03/23/21 Truist Truist sees mixed readthroughs to Wave's toplines from competitor HD setback 03/11/21 Mizuho Wave Life Sciences price target raised to $21 from $19 at Mizuho 03/04/21 Wave Life Sciences reports Q4 EPS (59c), consensus (61c) 11/09/20 Wave Life Sciences reports Q3 EPS (86c), consensus (69c)
Recommendations
Mizuho analyst Salim Syed…
Mizuho analyst Salim Syed lowered the firm's price target on Wave Life Sciences to $7 from $21 and keeps a Buy rating on the shares after the company's Phase 1b/2a Huntington's disease data failed on efficacy. "It didn't even get close to hitting what we had thought of as target range mHTT knockdown of 20-30%," Syed tells investors in a research note. The analyst believes the data "should be effectively the last of the weaker" first-generation chemistry from Wave Life, potentially marking a "clearing event from an investor sentiment point of view."
Show Hide Related Items >> <<
03/29/21 Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials 03/29/21 Wave Life Sciences provides update on Phase 1b/2a Precision-HD trials 03/04/21 Wave Life Sciences cash runway expected into 2Q23 01/11/21 Wave Life Sciences announces 2021 key upcoming milestones 03/30/21 RBC Capital Wave Life Sciences price target lowered to $8 from $13 at RBC Capital 03/23/21 Truist Truist sees mixed readthroughs to Wave's toplines from competitor HD setback 03/11/21 Mizuho Wave Life Sciences price target raised to $21 from $19 at Mizuho 12/15/20 H.C. Wainwright Wave Life Sciences assumed with a Buy at H.C. Wainwright 03/04/21 Wave Life Sciences reports Q4 EPS (59c), consensus (61c) 11/09/20 Wave Life Sciences reports Q3 EPS (86c), consensus (69c)